Cancer Therapy: Selectively Suppressing Tumor Angiogenesis for Targeted Breast Cancer Therapy by Genetically Engineered Phage (Adv. Mater. 29/2020)

Nontoxic phage virus nanofibers are genetically engineered by Mingying Yang, Chuanbin Mao, and co-workers in article number 2001260 to first home to tumors through the blood circulation and then capture proteins that can promote blood vessel formation in the tumors. The phages are thus able to suppress tumor growth due to the inhibition of the tumor angiogenesis.